Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine.
Lien
E A
EA
Department of Clinical Biology, University of Bergen, Norway.
Anker
G
G
Lønning
P E
PE
Refsum
H
H
Ueland
P M
PM
D000616:Aminoglutethimide / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000517:prevention & control; D001943:Breast Neoplasms / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease / Q000517:prevention & control; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000453:epidemiology / Q000517:prevention & control; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen; D006710:Homocysteine; D000616:Aminoglutethimide; D002784:Cholesterol